This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ciardiello, F. Articles by Salomon, D. S. Search for Related Content PubMed PubMed Citation Articles by Ciardiello, F. Articles by Salomon, D. S.

Differential Growth Sensitivity to 4-cis-Hydroxy-L-proline of Transformed Rodent Cell Lines

Laboratory of Tumor Immunology and Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892

The effect of 4-cis-hydroxy-L-proline (CHP), a proline analogue, on the anchorage-dependent and -independent growth of several transformed rodent cell lines was studied. Mouse NIH-3T3 fibroblasts transformed by a variety of different oncogenes (Ki-ras, mos, src, fms, fes, met, and trk) by a DNA tumor virus (SV40) or by a chemical carcinogen (N-methylnitrosourea) were all found to be more sensitive (50% inhibitory dose, 20 to 55 µg/ml) to the dose-dependent inhibitor effects of CHP on growth in monolayer culture than were NIH-3T3 cells (50% inhibitory dose, 120 µg/ml). CHP was generally found to be even more effective in inhibiting the growth of these transformed cells as colonies in soft agar than in monolayer cultures. In addition, rat embryo fibroblasts (CREF) and normal rat kidney fibroblasts (NRK) after transformation with a Ki-ras oncogene exhibit a similar increase in their sensitivity to CHP-induced growth inhibition. Treatment of NRK cells with transforming growth factor (TGF-) and ß (TGF-ß), which reversibly induces phenotypic transformation of these cells, increases their sensitivity to CHP to a level comparable with that observed in Ki-ras-transformed NRK cells (K-NRK). The growth inhibitory effects of CHP are reversible, since removal of CHP results in a normal resumption of cell growth. CHP uptake occurs primarily through the Na⁺- and energy-dependent neutral amino acid transport A system, which is 6- to 7-fold more elevated in K-NRK cells compared with NRK cells. Treatment of NRK cells with TGF- and/or -ß increases the uptake of [³H]methylaminoisobutyric acid on the A system to a level that is similar to that found in K-NRK cells. The functions of the Na⁺/K⁺ and Na⁺/H⁺ exchange systems are apparently necessary for the enhanced A system activity, since ouabain and amiloride can inhibit the uptake of [³H]methylaminoisobutyric acid in K-NRK cells and in NRK cells treated with TGF- and/or -ß. The activity of the A system is specifically increased in K-NRK and in TGF-- and/or -ß-treated NRK cells, since the other two major neutral amino acid uptake systems, the ASC and the L systems, and the Ly⁺ system for basic amino acid uptake show no apparent changes in their activity in NRK cells after treatment with TGF- and/or -ß or in these cells after transformation with the Ki-ras oncogene. These results suggest that the differential growth sensitivity to CHP of transformed rodent cells and of normal fibroblasts treated with TGF- and/or -ß is due in part to an elevated uptake of this amino acid analogue on the neutral amino acid transport A system.

¹ To whom requests for reprints should be addressed, at Laboratory of Tumor Immunology and Biology, Building 10, Room 5B43, National Cancer Institute, NIH, Bethesda, MD 20892.

Received 9/28/87. Revised 1/12/88. Accepted 1/26/88.

This article has been cited by other articles:

				L. Metzner, J. Kalbitz, and M. Brandsch Transport of Pharmacologically Active Proline Derivatives by the Human Proton-Coupled Amino Acid Transporter hPAT1 J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 28 - 35. [Abstract] [Full Text]